 |
|
|
 |
Information for clinicians: General questions and answers about the 2003-2004 influenza season
Production of influenza vaccines is a complex process that requires many steps, including selection of suitable vaccine viruses, growth of these viruses in eggs, and testing to ensure safety and purity of the vaccine. Recommendations about which strains should go into the vaccines for the United States are based on year-round surveillance and are typically made in February for vaccine that will be used in the
following season. more
|
|
Clinical guidance on the identification and evaluation of possible SARS-CoV disease among persons presenting with community-acquired illness
This document, from the Centers for Disease Control provides guidance on the clinical evaluation and management of patients who present from the community with fever and/or respiratory illnesses. Recommendations supercede those in the draft, Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS), which is currently being revised and finalized. Recommendations also supercede other SARS-related CDC materials on relevant topics that are under review. more
|
|
Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) (1.5mb PDF)
The Centers for Disease Control and Prevention (CDC) is making this document available in draft form to assist local and state public health and healthcare officials in their preparations for a possible reemergence of SARS during the approaching respiratory disease season. The proposed framework and strategies for SARS preparedness and response are based on lessons learned from the 2003 global SARS epidemic and the advice and suggestions of domestic and international public health and healthcare partners. The document is currently undergoing external review by partner organizations and other federal agencies and will be updated as necessary to incorporate comments from reviewers and to reflect increased understanding of SARS-CoV transmission dynamics and the availability of improved prevention tools. more
|
|
|
|
Vidyya bioterrorism page: Frequently asked questions about a nuclear blast
With the recent threats of terrorism, many people have expressed concern about the likelihood and effects of a nuclear blast. The Centers for Disease Control and Prevention (CDC) has developed this fact sheet to describe what happens when a nuclear blast occurs, the possible health effects, and what can be done for protection in this type of emergency.
more
|
|
Information for patients: Snort, sniffle, sneeze. No antibiotics please. (PDF)
As parents, your patients want to help their children feel better. But antibiotics aren’t always the answer. They don’t fight the viruses that cause colds and flu. What will? Fluids and plenty of rest are best. Talk to your patients. Make sure they understand when antibiotics work – and when they don’t. The best care is the right care.
more
|
|
Persistently abnormal liver function tests: Marker of occult hepatitis C?
Patients with persistently abnormal liver function tests but no serologic evidence of liver disease may nevertheless have hepatitis C virus (HCV) infection, according to a study published in the 1 January issue of The Journal of Infectious Diseases.
more
|
|
East meets West with a traditional herbal cure for jaundice
In the 2 January issue of the Journal of Clinical Investigation, David Moore and colleagues from Baylor College of Medicine, Texas, demonstrate that a Chinese herbal tea remedy for jaundice called Yin Zhi Huang (YZH) activates a liver receptor that enhances the clearance of bilirubin. YZH was "boiled down" to one component: 6,7-dimethylesculetin, which binds to and activates the hepatic nuclear receptor CAR and its target genes, leading to increased clearance of bilirubin.
more
|
|
|
